Skip to main content

Published locations for Aggregate response benefit in skin clearance and itch reduction favor upadacitinib over dupilumab in AD

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Aggregate response benefit in skin clearance and itch reduction favor upadacitinib over dupilumab in AD

User login

  • Reset your password
  • /content/aggregate-response-benefit-skin-clearance-and-itch-reduction-favor-upadacitinib-over
  • /dermatology/article/267335/atopic-dermatitis/aggregate-response-benefit-skin-clearance-and-itch